"California Dermatology is a premier, dermatology research center in Encinitas, California. We conduct clinical research trials for a variety of dermatological conditions - eczema, psoriasis, alopecia, hyperhidrosis, acne and more - and we're always looking for qualified volunteers to participate. You will find the most cutting edge therapies and top of the line technology here. We have decades of experience in executing clinical research in dermatology and we pride ourselves on treating all participants professionally and with respect."

During the past decade, California Dermatology & Clinical Research Institute conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 28 clinical trials were completed, i.e. on average, 65.1% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 19 clinical trials were completed. i.e. 82.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "California Dermatology & Clinical Research Institute" #1 sponsor was "Pfizer" with 12 trials, followed by "Eli Lilly and Company" with 10 trials sponsored, "Journey Medical Corporation" with 5 trials sponsored, "Meda Pharmaceuticals" with 4 trials sponsored and "Concert Pharmaceuticals" with 4 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "California Dermatology & Clinical Research Institute" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Symbio, LLC" with 3 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator, "Nektar Therapeutics" with 2 trials as a collaborator and "Prosoft Clinical" with 2 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "California Dermatology & Clinical Research Institute" are "Atopic Dermatitis" (11 trials), "Psoriasis" (7 trials), "Alopecia Areata" (5 trials), "Plaque Psoriasis" (5 trials) and "Hyperhidrosis" (4 trials). Many other conditions were trialed in "California Dermatology & Clinical Research Institute" in a lesser frequency.

Most popular intervention types in "California Dermatology & Clinical Research Institute" are "Drug" (45 trials), "Other" (9 trials), "Biological" (4 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Vehicle" (5 trials), "Baricitinib" (3 trials), "PF-06700841" (3 trials) and "fluticasone propionate" (3 trials). Other intervention names were less common.

The vast majority of trials in "California Dermatology & Clinical Research Institute" are 51 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "California Dermatology & Clinical Research Institute". undefined are not yet recruiting, 3 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 35 completed trials in California Dermatology & Clinical Research Institute, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in California Dermatology & Clinical Research Institute, 5 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".